Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: joint pain; feeling unwell; bursitis; legs are still very sore; a lot more redness; pain and itching at the injection site; pain and itching at the injection site; Lymphadenopathy returned to the lymph nodes; fever; she also was drenching with sweat; a little injection site swelling; headache that lasted 18-20 hours; muscle pain; chills; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 72-year-old female patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number: EW0151, Expiration Date: was not reported) via an unspecified route of administration, administered in left arm, on 29Apr2021 09:00 (at the age of 72 year), as dose 2, single for COVID-19 immunization. Medical history included bursitis from 18Jan2021 to an unknown date, COVID-19 from Nov2020 to an unknown date. Concomitant medication included paracetamol (TYLENOL) 500 mg twice a day, via oral route of administration, taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number: EW0151, Expiration Date: was not reported) via an unspecified route of administration, administered in left arm, on 08Apr2021 (at the age of 72 year), as dose 1, single for COVID-19 immunization and the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, feeling unwell, lymphadenopathy. The patient had no history of all previous immunization with the Pfizer vaccine considered as suspect. The patient was not received additional vaccines administered on same date of the Pfizer suspect. The adverse events were not resulted in emergency room or physician office visit. The patient was not received prior vaccination within four weeks. The patient was not experienced adverse events following prior vaccination. The patient stated, after having COVID-19, she had bursitis pain in mid Nov2020. The patient stated, she did not go for treatment initially. The patient stated, she was seen by the doctor and was diagnose on 18Jan2021. The patient has read through the literature. The patient and her husband had COVID-19 in Nov2020. The patient had the first dose of the vaccine on 08Apr2021. The patient had 11 of 12 the side effects listed. The patient was miserable for about 10 days after the vaccine. The patient was due to get the second dose on 29Apr2021. The patient contacted her doctor and asked if she should proceed because she was worried. The patient doctor advised that she follow up with the recommended program and she did. The patient experience was much better. The patient had minimal side effects lasting 3 days. The patient is still having ongoing issues from having COVID-19 in Nov2020. The patient called to report the side effects that she experienced. The patient has horrible bursitis in both hips from recovering from COVID-19, this includes multiple joints, both hips, ankles, shoulder and wrist. As reported, with the first dose the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, feeling unwell, lymphadenopathy. The patient was unable to state if muscle pain has resolved or is ongoing. The patient legs are still very sore. The patient general muscle pain has improved, the chills were off and on through 15Apr2021, the lymph node is still tender. The patient was not sure if the first dose was given in the muscle. The patient stated the injection was given so high in the muscle. The patient stated, she had immediate pain with the injection, and it is still tender today. The patient spoke with nurse about the first one. The patient stated the nurse was careful to give the second dose 4 inches lower compared to the first dose. The patient stated it was better experience. After second dose on 29Apr2021, the patient had a headache that lasted 18-20 hours and muscle pain. The patient started with chills that were off and on for 2 days. At the same time the patient had chills. The patient was also drenching with sweat on 30Apr2021. The patient relates this to the chills. The patient also experienced joint pain which is still ongoing since after first dose. On 29Apr2021, the patient experienced a little injection site swelling. On 30Apr2021, the patient experienced fever. On 02May2021, the patient experienced a lot more redness, pain and itching at the injection site. The patient also has been feeling unwell since the first dose that is still ongoing. The patient stated, the lymphadenopathy returned to the lymph nodes on 01May2021, it was so sore with the first dose. The patient stated, it was so bad, she was unable to put her arm straight down her side. The patient stated, her orthopedic doctor diagnosed her with bursitis. The patient stated, she was treated with Cortisone. The patient stated, she saw the doctor on 28Dec2020. The patient stated, she was put on Valtaren because of multiple joint pain in her ankles, both hips, left shoulder and left wrist. The patient stated the last set of labs she had drawn was in Dec2020. The patient stated, she had a flu shot in Oct2020. The patient stated, she still has ongoing symptoms. The patient stated, she had head fog since prior to getting the vaccine, and after having COVID-19. The outcome of joint pain, feeling unwell, bursitis, legs are sore was unknown. The outcome of headache, muscle pain was recovered on 30Apr2021. The outcome of chills was recovered on 01May2021. The outcome of fever was recovered on 02May2021. The outcome of drenching with sweat was recovered on 03May2021. The outcome of injection site swelling was recovered on 05May2021. The outcome of injection site redness, injection site pain was recovered on 06May2021. The outcome of injection site itching was recovered on 08May2021. The outcome of lymphadenopathy was recovered on 10May2021.  No follow-up attempts completed. No further information expected.